This has been the most impressive presentation so far. If this drug passes clinical trials I think it will be a blockbuster.
This has been the most impressive presentation so far. If this drug passes clinical trials I think it will be a blockbuster.
4 Likes
And the name of the drug? When will it be available?
3 to 5 years … if we are lucky. See this thread … The Culprit of Aging - Helen Blau's work at Stanford / PGE2, 15-PDGH
This is misleading IMO unless you redefine “aging” to something else… but even if you did, why compare with those other things? There’s no adjustment for confounding.
You can’t compare a 35 year old with hypertension and 65 year old without.
When you adjust for confounding aging is not the cause.
It’s those other factors over time. LDL-C, hypertension, smoking, obesity…
So call it “Cumulative risk factor exposure”… and what does this have to do with aging? Is it underfunded? Why compare it with its constituent parts without time?
2 Likes